Juvenile Myositis (JM or JDM for Juvenile Dermatomyositis) is a rare autoimmune disease that affects about 5,000 children in...
Juvenile dermatomyositis (JDM) is a systemic, autoimmune inflammatory muscle disorder and vasculopathy that affects children younger than 18 years. JDM primarily affects the skin and the skeletal muscles.
Characteristic findings include Gottron’s papules, a heliotrope rash, calcinosis cutis, and symmetrical, proximal muscle weakness.
Juvenile Myositis (JM), including Juvenile Dermatomyositis (JDM) and Juvenile Polymyositis (JPM), are rare autoimmune conditions which cause inflammation. The inflammation for JPM primarily occurs in the muscles, while in JDM the inflammation is in the blood vessels that lie under the skin and in the muscle tissue. This inflammation causes weak muscles and – in the case of JDM – skin rashes. If blood vessels or muscle cells in other parts of the body are inflamed, other systems of the body can be affected, such as the digestive tract, heart, and lungs. The condition itself and the treatment for the disease can be life-threatening.
Search our site
- Myositis Smartphone App
- Myositis Awareness Month
- Explore Myositis
- Myositis Clinical Trials
- MSU Programs and Services
- Latest Myositis News
- Upcoming Events
- Donate today!
May 30 @ 2:00 pm - 2:45 pm EDT
PR: MSU, Portable Genomics teaming up to bring a tailored health data management platform to myositis patients May 16, 2018
Portable Genomics and Myositis Support and Understandin...
Speaking engagement about myositis at Corbus Pharmaceuticals May 15, 2018
Corbus Pharmaceuticals will host Jerry Williams, the Fo...